First Time Loading...

Qualigen Therapeutics Inc
NASDAQ:QLGN

Watchlist Manager
Qualigen Therapeutics Inc Logo
Qualigen Therapeutics Inc
NASDAQ:QLGN
Watchlist
Price: 0.291 USD -2.94%
Updated: May 1, 2024
Section:
 

Wall Street
Price Targets

QLGN Price Targets Summary
Qualigen Therapeutics Inc

There are no price targets for QLGN.
QLGN Lowest Forecast
Wall Street Target
Not Available
QLGN Average Forecast
Wall Street Target
Not Available
QLGN Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Qualigen Therapeutics Inc Competitors:
Price Targets
MRKR
Marker Therapeutics Inc
215% Upside
300406
Beijing Strong Biotechnologies Inc
19% Upside
ELEV
Elevation Oncology Inc
126% Upside
MOR
MorphoSys AG
14% Downside
MRKR
Marker Therapeutics Inc
215% Upside
300406
Beijing Strong Biotechnologies Inc
19% Upside
ELEV
Elevation Oncology Inc
126% Upside
MOR
MorphoSys AG
14% Downside
X
688278
Xiamen Amoytop Biotech Co Ltd
17% Downside
GRTS
Gritstone bio Inc
571% Upside
ARQT
Arcutis Biotherapeutics Inc
114% Upside
BIIB
Biogen Inc
42% Upside

Revenue
Forecast

Revenue Estimate
Qualigen Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Qualigen Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Qualigen Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-99%
Average Miss
What are analyst estimates?

See Also

Summary
QLGN intrinsic value, competitors valuation, and company profile.
DCF Valuation
QLGN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
QLGN stock valuation using valuation multiples.
Wall Street Estimates
QLGN price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
QLGN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is QLGN's stock price target?
Not Available

QLGN doesn't have any price targets made by Wall Street professionals.

ALPHA SPREAD
Join more than 133,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.